Effect of CR1 Genetic Variants on Cerebrospinal Fluid and Neuroimaging Biomarkers in Healthy, Mild Cognitive Impairment and Alzheimer's Disease Cohorts (Q46359830)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Effect of CR1 Genetic Variants on Cerebrospinal Fluid and Neuroimaging Biomarkers in Healthy, Mild Cognitive Impairment and Alzheimer's Disease Cohorts	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/26742530

Effect of CR1 Genetic Variants on Cerebrospinal Fluid and Neuroimaging Biomarkers in Healthy, Mild Cognitive Impairment and Alzheimer's Disease Cohorts (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/26742530

0 references

cerebrospinal fluid

0 references

1 reference

based on heuristic

inferred from title

mild cognitive impairment

1 reference

based on heuristic

inferred from title

Alzheimer's disease

1 reference

based on heuristic

inferred from title

cognitive dysfunction

1 reference

based on heuristic

inferred from title

Alzheimer's Disease Neuroimaging Initiative

10

object named as

Alzheimer’s Disease Neuroimaging Initiative

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

object named as

Jin-Tai Yu

9

0 references

8

object named as

Lan Tan

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

3

object named as

Teng Jiang

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/26742530

author name string

Xi-Chen Zhu

1

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/26742530

Hui-Fu Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/26742530

Huan Lu

4

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/26742530

Meng-Shan Tan

5

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/26742530

Chen-Chen Tan

6

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/26742530

Lin Tan

7

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/26742530

publication date

7 January 2016

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/26742530

Molecular Neurobiology

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/26742530

54

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/26742530

1

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/26742530

551-562

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/26742530

Epidemiology and etiology of Alzheimer's disease: from genetic to non-genetic factors

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Epidemiology of Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Angiotensin-(1-7) induces cerebral ischaemic tolerance by promoting brain angiogenesis in a Mas/eNOS-dependent pathway

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Genetics of Alzheimer's disease: a centennial review

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Replication of CLU, CR1, and PICALM associations with alzheimer disease.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Complement receptor 1 polymorphisms and risk of late-onset Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Polymorphisms of CR1, CLU and PICALM confer susceptibility of Alzheimer's disease in a southern Chinese population.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Implication of common and disease specific variants in CLU, CR1, and PICALM.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Genetic association of CR1 with Alzheimer's disease: a tentative disease mechanism

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Complement receptor 1 coding variant p.Ser1610Thr in Alzheimer's disease and related endophenotypes

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Evaluation of late-onset Alzheimer disease genetic susceptibility risks in a Canadian population.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Complement activation by beta-amyloid in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Peripheral clearance of amyloid beta peptide by complement C3-dependent adherence to erythrocytes.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Systemic catabolism of Alzheimer's Abeta40 and Abeta42.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

CR1 in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Inflammation, the complement system and the diseases of aging

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

CR1 is associated with amyloid plaque burden and age-related cognitive decline

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Apolipoprotein E, not fibrillar β-amyloid, reduces cerebral glucose metabolism in normal aging

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Effect of EPHA1 genetic variation on cerebrospinal fluid and neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer's disease cohorts

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Bridging integrator 1 (BIN1) protein expression increases in the Alzheimer's disease brain and correlates with neurofibrillary tangle pathology

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Bridging Integrator 1 (BIN1) Genotype Effects on Working Memory, Hippocampal Volume, and Functional Connectivity in Young Healthy Individuals

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Genetic variation and neuroimaging measures in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Neuroimaging to assess safety and efficacy of AD therapies

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Temporoparietal MR imaging measures of atrophy in subjects with mild cognitive impairment that predict subsequent diagnosis of Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Association between NME8 locus polymorphism and cognitive decline, cerebrospinal fluid and neuroimaging biomarkers in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Mild cognitive impairment as a diagnostic entity

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Association of GWAS top hits with late-onset Alzheimer disease in Korean population.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Testing for associations between loci and environmental gradients using latent factor mixed models.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Complement receptor 1 gene variants are associated with erythrocyte sedimentation rate

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Genome-wide association analysis of metabolic traits in a birth cohort from a founder population

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Alzheimer's disease is associated with low density of the long CR1 isoform.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

CR1 is potentially associated with rate of decline in sporadic Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Meta-analysis of the association between CR1 polymorphisms and risk of late-onset Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Genotype patterns at CLU, CR1, PICALM and APOE, cognition and Mediterranean diet: the PREDIMED-NAVARRA trial

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

A coding variant in CR1 interacts with APOE-ε4 to influence cognitive decline

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Use of Florbetapir-PET for Imaging β-Amyloid Pathology

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Sequence-independent segmentation of magnetic resonance images.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Brain amyloid-β burden is associated with disruption of intrinsic functional connectivity within the medial temporal lobe in cognitively normal elderly

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

MRI measures of entorhinal cortex vs hippocampus in preclinical AD.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Animal model of posterior cingulate cortex hypometabolism implicated in amnestic MCI and AD.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Imbalance in fatty-acid-chain length of gangliosides triggers Alzheimer amyloid deposition in the precuneus

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Comprehensive dissection of the medial temporal lobe in AD: measurement of hippocampus, amygdala, entorhinal, perirhinal and parahippocampal cortices using MRI.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Heightened emotional contagion in mild cognitive impairment and Alzheimer's disease is associated with temporal lobe degeneration

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

MRI hippocampal and entorhinal cortex mapping in predicting conversion to Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Link between hippocampus' raised local and eased global intrinsic connectivity in AD.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

The amnestic syndrome of hippocampal type in Alzheimer's disease: an MRI study.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

More powerful procedures for multiple significance testing

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Genetic association of complement receptor 1 polymorphism rs3818361 in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Depressive symptoms accelerate cognitive decline in amyloid-positive MCI patients

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Multimodal MRI-based Imputation of the Aβ+ in Early Mild Cognitive Impairment

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Genetic variation at CR1 increases risk of cerebral amyloid angiopathy

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Clinical and biomarker changes in dominantly inherited Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Commentary on "Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease." Addressing the challenge of Alzheimer's disease in the 21st century.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Long-term seizure, cognitive, and psychiatric outcome following trans-middle temporal gyrus amygdalohippocampectomy and standard temporal lobectomy

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Neuroanatomical correlates of awareness of illness in patients with amnestic mild cognitive impairment who will or will not convert to Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Association between white matter hyperintensity and medial temporal atrophy at various stages of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Imaging local brain function with emission computed tomography

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Topographic patterns of brain functional impairment progression according to clinical severity staging in 116 Alzheimer disease patients: FDG-PET study.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

CR1 and the "vanishing amyloid" hypothesis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Deletion of Crry, the murine ortholog of the sporadic Alzheimer's disease risk gene CR1, impacts tau phosphorylation and brain CFH.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Missense variants in CR1 are associated with increased risk of Alzheimer' disease in Han Chinese

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9638-8

21 January 2018

Fangotherapy and diacerein in the treatment of osteoarthrosis of the hip and knee

1 reference

https://pubmed.ncbi.nlm.nih.gov/26742530

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

THE PSYCHOLOGICAL CORPORATION

1 reference

https://pubmed.ncbi.nlm.nih.gov/26742530

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cerebrovascular disease: CR1 variant increases risk of cerebral amyloid angiopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26742530

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12035-015-9638-8

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/26742530

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/26742530

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46359830&oldid=2207817434"